The revised guidelines stress the use of high-quality imaging and consistency in images taken.
People with MS who have comorbidities may be more likely to experience disruptive pain.
Another study suggests that a telehealth system could help objectively monitor dose adherence.
Rates were similar, but gender and age-specific differences emerged.
Insurance coverage can be the determining factor on whether a patient receives DMT or not.
A team to address both the physical and emotional outcomes of MS relapse is essential to high quality care.
A combination of physical, occupational, hand, speech, cognitive, and behavioral therapy improves outcomes.
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- FDA: Lamotrigine Linked to Potentially Life-Threatening Adverse Reaction
- Psychological Therapies May Help Older Adults With Chronic Pain
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics